Phenotype and Treatment of Breast Cancer in HIV-Positive and -Negative Women in Cape Town, South Africa
Open Access
- 1 October 2016
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Global Oncology
- Vol. 2 (5) , 284-291
Abstract
Purpose: An estimated 5.9 million people in South Africa are infected with HIV. Because antiretroviral therapy has made infection with HIV a treatable, chronic condition, HIV-infected individuals are now surviving to middle and older age. We investigated the implications of HIV status for breast cancer in South Africa. Methods: We compared clinical and demographic characteristics of women newly diagnosed with a first primary breast cancer at Tygerberg Hospital, Cape Town, South Africa, from January 2010 to December 2011 by HIV status. We then compared HIV-positive patients with HIV-negative controls, matched 2:1 on age and ethnicity, with respect to chemotherapy regimens, toxicities, completion of systemic chemotherapy, and changes in CD4 cell count. Results: Of 586 women with breast cancer, 31 (5.3%) were HIV positive, 420 (71.7%) were HIV negative, and 135 (23%) were untested for HIV. Women with HIV were younger than other women (P < .001). The groups did not differ in regard to stage at presentation, histologic subtype, tumor grade, nodal involvement, or hormone receptor positivity. More than 84% of patients who initiated systemic chemotherapy, regardless of HIV status, completed it without serious toxicity. Among HIV-positive patients receiving chemotherapy, the mean baseline CD4 cell count was 477 cells/µL (standard deviation, 160 cells/µL), and the mean nadir was 333 cells/µL (standard deviation, 166 cells/µL). Conclusion: HIV-infected women were younger at breast cancer diagnosis than HIV-negative women but otherwise similar in phenotype and completion of chemotherapy. Longer term follow-up is needed to evaluate the effects of HIV, antiretroviral therapy, and chemotherapy on the survival and quality of life of patients with breast cancer.Keywords
This publication has 23 references indexed in Scilit:
- Breast cancer characteristics and HIV among 1,092 women in Soweto, South AfricaBreast Cancer Research and Treatment, 2013
- Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort StudyHIV Medicine, 2012
- Completion of and early response to chemoradiation among human immunodeficiency virus (HIV)‐positive and HIV‐negative patients with locally advanced cervical carcinoma in South AfricaCancer, 2011
- Risk of Human Papillomavirus–Associated Cancers Among Persons With AIDSJNCI: Journal of the National Cancer Institute, 2009
- Cancer risk in people infected with human immunodeficiency virus in the United StatesInternational Journal of Cancer, 2008
- Immunologic recovery in survivors following chemotherapy for AIDS-related non-Hodgkin lymphomaBlood, 2008
- AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy eraCurrent Opinion in Oncology, 2007
- Trends in cancer risk among people with AIDS in the United States 1980–2002AIDS, 2006
- Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010Blood, 2005
- Opportunistic Infection and Immunologic Function in Patients With Human Immunodeficiency Virus-Associated Non-Hodgkin's Lymphoma Treated With ChemotherapyJNCI: Journal of the National Cancer Institute, 1997